Simplex Trading’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.4M | Sell |
39,000
-400
| -1% | -$187K | 0.01% | 474 |
|
|
2025
Q4 | $17.9M | Sell |
39,400
-1,800
| -4% | -$776K | 0.01% | 598 |
|
|
2025
Q3 | $16.1M | Buy |
41,200
+11,700
| +40% | +$4.89M | 0.01% | 727 |
|
|
2025
Q2 | $13.1M | Sell |
29,500
-34,400
| -54% | -$15.9M | 0.01% | 715 |
|
|
2025
Q1 | $31M | Sell |
63,900
-24,000
| -27% | -$11.2M | 0.02% | 389 |
|
|
2024
Q4 | $35.4M | Buy |
87,900
+28,700
| +48% | +$13.3M | 0.02% | 408 |
|
|
2024
Q3 | $27.5M | Buy |
59,200
+17,600
| +42% | +$8.45M | 0.02% | 513 |
|
|
2024
Q2 | $19.5M | Sell |
41,600
-18,800
| -31% | -$8.16M | 0.01% | 629 |
|
|
2024
Q1 | $25.2M | Sell |
60,400
-33,600
| -36% | -$14.2M | 0.01% | 580 |
|
|
2023
Q4 | $38.2M | Buy |
94,000
+32,500
| +53% | +$12M | 0.02% | 433 |
|
|
2023
Q3 | $21.4M | Buy |
61,500
+6,900
| +13% | +$2.41M | 0.02% | 564 |
|
|
2023
Q2 | $19.2M | Buy |
54,600
+23,700
| +77% | +$7.99M | 0.02% | 591 |
|
|
2023
Q1 | $9.73M | Sell |
30,900
-14,500
| -32% | -$4.35M | 0.01% | 920 |
|
|
2022
Q4 | $13.1M | Sell |
45,400
-2,100
| -4% | -$640K | 0.01% | 732 |
|
|
2022
Q3 | $13.8M | Sell |
47,500
-3,300
| -6% | -$949K | 0.02% | 655 |
|
|
2022
Q2 | $14.3M | Sell |
50,800
-18,700
| -27% | -$5.01M | 0.02% | 645 |
|
|
2022
Q1 | $18.1M | Buy |
69,500
+3,400
| +5% | +$807K | 0.02% | 573 |
|
|
2021
Q4 | $14.5M | Sell |
66,100
-18,900
| -22% | -$3.68M | 0.01% | 622 |
|
|
2021
Q3 | $17.2M | Buy |
85,000
+100
| +0.1% | +$19.5K | 0.02% | 508 |
|
|
2021
Q2 | $17.1M | Buy |
84,900
+84,205
| +12,116% | +$17.6M | 0.02% | 499 |
|
|
2021
Q1 | $14.9M | Buy |
+695
| New | +$153K | 0.03% | 343 |
|
|
2020
Q2 | – | Sell |
-491
| Closed | -$11.7M | – | 8447 |
|
|
2020
Q1 | $11.7M | Sell |
491
-107
| -18% | -$24.5K | 0.02% | 360 |
|
|
2019
Q4 | $13.1M | Sell |
598
-202
| -25% | -$40.9K | 0.03% | 386 |
|
|
2019
Q3 | $13.6M | Buy |
800
+266
| +50% | +$47.1K | 0.04% | 327 |
|
|
2019
Q2 | $9.79M | Sell |
534
-129
| -19% | -$22.6K | 0.03% | 413 |
|
|
2019
Q1 | $12.2M | Sell |
663
-154
| -19% | -$28.4K | 0.03% | 334 |
|
|
2018
Q4 | $13.5M | Buy |
817
+549
| +205% | +$95.1K | 0.04% | 281 |
|
|
2018
Q3 | $5.17M | Sell |
268
-304
| -53% | -$54.1K | 0.02% | 603 |
|
|
2018
Q2 | $9.72M | Sell |
572
-15
| -3% | -$2.33K | 0.04% | 353 |
|
|
2018
Q1 | $513K | Buy |
587
+267
| +83% | +$43.6K | 0.02% | 700 |
|
|
2017
Q4 | $1.06M | Sell |
320
-443
| -58% | -$65.6K | 0.05% | 376 |
|
|
2017
Q3 | $1.73M | Sell |
763
-75
| -9% | -$11.3K | 0.07% | 225 |
|
|
2017
Q2 | $1.02M | Sell |
838
-114
| -12% | -$13.7K | 0.04% | 358 |
|
|
2017
Q1 | $1.73M | Buy |
952
+204
| +27% | +$18K | 0.08% | 229 |
|
|
2016
Q4 | $246K | Buy |
748
+501
| +203% | +$40.8K | 0.01% | 912 |
|
|
2016
Q3 | $35K | Buy |
247
+124
| +101% | +$11.7K | ﹤0.01% | 2433 |
|
|
2016
Q2 | $23K | Buy |
123
+32
| +35% | +$2.77K | ﹤0.01% | 2789 |
|
|
2016
Q1 | $19K | Sell |
91
-100
| -52% | -$9.04K | ﹤0.01% | 2865 |
|
|
2015
Q4 | $439K | Sell |
191
-82
| -30% | -$9.9K | 0.03% | 480 |
|
|
2015
Q3 | $263K | Buy |
273
+99
| +57% | +$12.7K | 0.02% | 765 |
|
|
2015
Q2 | $300K | Buy |
174
+33
| +23% | +$4.16K | 0.03% | 586 |
|
|
2015
Q1 | $201K | Sell |
141
-175
| -55% | -$21K | 0.02% | 727 |
|
|
2014
Q4 | $1.3M | Buy |
+316
| New | +$35.6K | 0.16% | 113 |
|
Other funds holding VRTX
VCM
VPM
Simplex Trading's VRTX Position: Q1 2026 in Review
Simplex Trading reduced its Vertex Pharmaceuticals (VRTX) stake by 60% in Q1 2026, selling an estimated $984K and leaving 1,401 shares worth $626K. The position accounts for ﹤0.01% of the portfolio, ranked #3015.
Simplex Trading first reported a position in VRTX in Q1 2015 and has held it in 30 quarters since. The position peaked at $4.78M in Q1 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Simplex Trading held 1,401 shares of Vertex Pharmaceuticals worth $626K as of Q1 2026.
- Simplex Trading sold 2,110 Vertex Pharmaceuticals shares in Q1 2026, an estimated $984K.
- Vertex Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #3015 holding.
- Simplex Trading first reported a position in Vertex Pharmaceuticals in Q1 2015 and has held it in 30 quarters since.
- Simplex Trading's Vertex Pharmaceuticals position peaked at $4.78M in Q1 2024.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.